Rat Coronavirus: Veterinary Reference

Overview and Taxonomy of Rat Coronavirus: Veterinary Reference

Introduction to Rat Coronavirus: A Neglected Pathogen in the Rodentia

The Coronaviridae family, a vast assemblage of enveloped, positive-sense single-stranded RNA viruses, is characterized by its remarkable genetic plasticity, broad host range, and capacity for cross-species transmission. Within this family, the Betacoronavirus genus harbors several pathogens of significant veterinary and public health importance, including the causative agents of severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), and the COVID-19 pandemic (SARS-CoV-2). While the global focus has rightly centered on these emergent human pathogens, the coronaviruses circulating within rodent populations, particularly the rat coronavirus (RCoV), represent a critical, yet often underappreciated, component of the coronaviral landscape. Rats (Rattus norvegicus and Rattus rattus) serve as ubiquitous synanthropic reservoirs, living in close proximity to human populations, livestock, and companion animals. This ecological niche positions them as potential hubs for viral evolution, recombination, and spillover events. Understanding the taxonomy, molecular phylogeny, and pathobiology of rat coronavirus is therefore not merely an academic exercise in veterinary virology; it is a cornerstone of a comprehensive One Health surveillance strategy aimed at anticipating and mitigating future zoonotic threats.

Rat coronavirus, historically referred to as sialodacryoadenitis virus (SDAV) due to its characteristic tropism for the salivary, lacrimal, and Harderian glands, is a prototypical member of the Betacoronavirus genus, specifically classified within the subgenus Embecovirus. This subgenus is distinguished by the presence of a hemagglutinin-esterase (HE) gene, a feature shared with other embecoviruses such as bovine coronavirus (BCoV), human coronavirus OC43 (HCoV-OC43), and porcine hemagglutinating encephalomyelitis virus (PHEV). The presence of the HE protein, which facilitates reversible binding to sialic acid receptors, is a defining molecular characteristic that influences tissue tropism and pathogenesis. The taxonomic placement of RCoV is unequivocally within the Betacoronavirus genus, a conclusion consistently supported by phylogenetic analyses of conserved structural proteins, including the spike (S), envelope (E), membrane (M), and nucleocapsid (N) proteins [1]. These analyses demonstrate that RCoV segregates robustly with other betacoronaviruses, distinct from the alphacoronaviruses (e.g., feline coronavirus, canine coronavirus) and gammacoronaviruses (e.g., avian infectious bronchitis virus) [1]. This foundational taxonomic understanding is essential for predicting viral behavior, identifying potential therapeutic targets, and interpreting cross-species infection risks.

Molecular Phylogeny and Genetic Relationships

The molecular phylogeny of rat coronavirus reveals a complex evolutionary history characterized by both conservation and divergence. Comprehensive protein sequence alignments and phylogenetic tree construction for the S, E, M, and N proteins have consistently demonstrated that these structural proteins segregate according to their viral genera [1]. For RCoV, this places it in a clade with other betacoronaviruses, including BCoV and HCoV-OC43. However, the spike protein, the primary determinant of host range and cell tropism, exhibits a more nuanced evolutionary pattern. While the overall phylogeny of the S protein aligns with the genus-level classification, studies have noted that the S proteins of alphacoronaviruses, in particular, lack strict conservation of phylogeny, suggesting a history of recombination events [1]. This phenomenon is not exclusive to alphacoronaviruses; recombination is a well-documented driving force in coronavirus evolution, and the S gene is a frequent hotspot for such genetic exchange. The potential for recombination between RCoV and other coronaviruses circulating in sympatric rodent or mammalian populations is a significant concern, as it could lead to the emergence of novel viruses with altered host tropism or increased virulence.

A particularly salient finding from comparative genomic studies is the presence of the polybasic furin cleavage motif (e.g., RRAR) at the S1/S2 junction of the spike protein. This motif, famously present in SARS-CoV-2 and critical for its efficient entry into host cells, is not unique to that virus. Indeed, it has been identified in several other betacoronaviruses and even a few alpha- and gammacoronaviruses of animals [1]. The presence of this motif in animal coronaviruses, including potential ancestors or relatives of RCoV, provides a strong counternarrative to the theory of a laboratory-engineered origin for SARS-CoV-2 and points to the existence of an intermediate host where such a motif could have been acquired through natural recombination [1]. For the veterinary virologist, the presence of a furin cleavage site in an RCoV strain would be a marker of significant pathogenic potential, warranting further investigation into its cell entry mechanisms and tissue tropism. The conservation of this motif across diverse coronaviruses underscores the importance of continuous genomic surveillance of animal reservoirs, including rats, to identify and characterize such genetic determinants of cross-species infectivity.

Host Range, Receptors, and the One Health Context

The host range of rat coronavirus is primarily considered to be restricted to rodents, particularly laboratory and wild rats. However, the potential for spillover into other species, including humans, is a question of paramount importance in the context of pandemic preparedness. The primary cellular receptor for embecoviruses, including RCoV, is 9-O-acetylated sialic acid, which is bound by the HE protein. However, the spike protein of some betacoronaviruses, such as SARS-CoV-2 and HCoV-NL63, utilizes angiotensin-converting enzyme 2 (ACE2) as its receptor. The conservation of critical ACE2 residues essential for SARS-CoV-2 spike protein binding has been shown to be most conserved in white-tailed deer and cattle, but less so in rodents [1]. This suggests that direct transmission of a SARS-CoV-2-like virus from rats to humans via the ACE2 pathway may be less likely, but it does not preclude the possibility of adaptation or the use of alternative receptors.

Furthermore, the host enzymes and receptors involved in coronavirus entry and replication, such as aminopeptidase N (APN), transmembrane serine protease 2 (TMPRSS2), dipeptidyl peptidase 4 (DPP4), and furin, retain host species-dependent relationships with one another [1]. This means that the compatibility of a viral spike protein with a host's cellular machinery is a finely tuned, species-specific interaction. While similarities in host enzymes and receptors do not always explain natural cross-infections, they provide a framework for assessing risk [1]. The rat, as a widely distributed and genetically diverse species, could serve as a "mixing vessel" where different coronaviruses coinfect and recombine, potentially generating viruses with novel receptor-binding capabilities. The World Health Organization (WHO) and the World Organisation for Animal Health (WOAH) have increasingly emphasized the need for surveillance in animal populations, particularly rodents, to identify and characterize coronaviruses with pandemic potential. The study of RCoV is therefore not just a matter of veterinary medicine but a critical component of global health security.

Clinical Manifestations and Pathogenesis in Rats

In its natural host, rat coronavirus is primarily associated with respiratory and ocular disease, with the most well-characterized manifestation being sialodacryoadenitis. This condition is characterized by inflammation and necrosis of the salivary glands (particularly the submandibular and parotid glands), the lacrimal glands, and the Harderian gland. Clinically, infected rats may present with cervical swelling due to salivary gland enlargement, epiphora (excessive tearing), chromodacryorrhea (reddish-brown porphyrin staining around the eyes and nose), photophobia, and sneezing. In severe cases, corneal ulceration and keratitis can occur due to the loss of lacrimal gland function. The virus is highly contagious and spreads rapidly through direct contact and aerosolized respiratory secretions. In laboratory rodent facilities, an RCoV outbreak can be devastating, disrupting research protocols by causing clinical disease and, more insidiously, by inducing profound immunological and physiological changes that confound experimental data.

Beyond the classic sialodacryoadenitis, RCoV can also cause lower respiratory tract infections, including interstitial pneumonia, particularly in neonatal or immunocompromised animals. The virus has a tropism for respiratory epithelium, and infection can lead to ciliary damage, epithelial necrosis, and inflammation of the airways. The pathogenesis is driven by direct viral cytopathic effects and the host's inflammatory response. The virus can also be detected in the gastrointestinal tract, although enteric disease is less prominent than in other species infected with betacoronaviruses, such as BCoV. The systemic effects of infection, including transient immunosuppression and alterations in cytokine profiles, are of particular concern in research settings, as they can impact the outcomes of studies involving immunology, toxicology, and infectious disease. The Centers for Disease Control and Prevention (CDC) and other health authorities recognize the importance of specific pathogen-free (SPF) rodent colonies, and RCoV is a key pathogen that must be excluded from such facilities to ensure the validity of biomedical research.

Diagnostic Approaches and Surveillance

The diagnosis of rat coronavirus infection relies on a combination of clinical observation, serology, and molecular detection. In a laboratory animal setting, routine serological surveillance using enzyme-linked immunosorbent assays (ELISA) or immunofluorescence assays (IFA) is the standard method for monitoring colony health. These tests detect antibodies against RCoV, indicating past or current infection. However, serology cannot distinguish between active and resolved infection. For confirmation of active infection, reverse transcription-polymerase chain reaction (RT-PCR) targeting conserved regions of the viral genome, such as the RNA-dependent RNA polymerase (RdRp) gene or the nucleocapsid (N) gene, is the gold standard. Real-time RT-PCR (RT-qPCR) offers high sensitivity and specificity, allowing for the detection of viral RNA in nasal swabs, oropharyngeal swabs, or tissue homogenates.

The development of rapid antigen tests (RATs), which have been widely deployed for SARS-CoV-2 diagnosis in humans, has also been explored for veterinary applications. While RATs offer the advantages of speed, low cost, and point-of-care usability, their sensitivity is generally lower than that of RT-PCR, particularly in samples with low viral loads [2, 5, 6, 8-14]. Studies evaluating RATs for SARS-CoV-2 have shown that sensitivity is highly dependent on the viral load, as measured by the cycle threshold (Ct) value, with the best performance observed in samples with high viral loads (Ct < 25-30) [12, 13]. For RCoV, the application of RATs is less common, but the principles are transferable. A well-validated RAT could be a valuable tool for rapid screening during an outbreak in a rodent facility, allowing for immediate isolation of potentially infected animals. However, negative RAT results should always be confirmed by RT-PCR, especially in high-stakes research environments [5, 9]. The use of metatranscriptomic sequencing is an emerging approach that offers untargeted detection of all RNA viruses in a sample, providing a powerful tool for surveillance and discovery of novel or divergent RCoV strains [3]. This technique, while currently more expensive and computationally intensive than targeted PCR, has the potential to revolutionize our understanding of the viral diversity present in rodent populations.

Implications for Veterinary Practice and Research

For the veterinary practitioner, particularly those involved in laboratory animal medicine or the care of pet rats, an understanding of RCoV is essential. In pet rats, respiratory and ocular signs should prompt consideration of RCoV, although other pathogens (e.g., Mycoplasma pulmonis, Sendai virus) are also common. Diagnosis is often based on clinical signs and serology, as molecular testing may not be readily available. There is no specific antiviral treatment for RCoV; management is supportive, focusing on maintaining hydration, providing nutritional support, and managing secondary bacterial infections with appropriate antibiotics. Prevention through biosecurity is paramount. New animals should be quarantined and tested before introduction to an established colony. In research facilities, strict barrier housing, including the use of individually ventilated cages (IVCs), positive-pressure ventilation, and rigorous personal protective equipment (PPE) protocols, is necessary to prevent the introduction and spread of RCoV.

The impact of RCoV on biomedical research cannot be overstated. Infection can alter a wide range of physiological parameters, including immune function, hormone levels, and behavior, leading to irreproducible and invalid data. For example, studies on the effects of novel therapeutics, such as the 3CLpro inhibitor SHEN211, rely on the use of healthy, SPF rats to establish baseline pharmacokinetic and pharmacodynamic profiles [7]. An undetected RCoV infection could confound these results, leading to erroneous conclusions about drug safety and efficacy. Similarly, toxicological studies assessing the safety of veterinary pharmaceuticals, such as the polyherbal formulation Exapar Premix, require that test animals be free of intercurrent infections to ensure that any observed effects are attributable to the test article and not to an underlying disease process [4]. The use of RCoV-free rats is therefore a non-negotiable requirement for high-quality, reproducible biomedical research. The Food and Agriculture Organization (FAO) and other international bodies recognize the critical role of healthy animal models in advancing human and animal health, underscoring the importance of rigorous pathogen control in research colonies.

In conclusion, rat coronavirus is a significant pathogen in its own right, causing substantial morbidity in rodent populations and posing a major threat to the integrity of biomedical research. Its taxonomic position within the Betacoronavirus genus, its molecular relationship to other embecoviruses, and its potential for recombination and evolution make it a virus of considerable interest from a One Health perspective. Continued surveillance, genomic characterization, and a deep understanding of its pathogenesis are essential for managing its impact on veterinary medicine and for safeguarding the global research enterprise. The lessons learned from studying RCoV, from its receptor usage to its immune evasion strategies, provide invaluable insights that can be applied to the broader challenge of predicting and preventing the next coronavirus pandemic.

Molecular Phylogeny and Evolutionary Dynamics of Rat Coronavirus

The molecular phylogeny of rat coronavirus (RCoV) situates this pathogen within a complex and rapidly evolving landscape of Betacoronavirus lineage A (also referred to as Embecovirus), a subgenus that includes murine hepatitis virus (MHV), bovine coronavirus (BCoV), and human coronavirus OC43 (HCoV-OC43). Understanding the evolutionary dynamics of RCoV is not merely an academic exercise; it is fundamental to predicting cross-species transmission potential, assessing zoonotic risk, and informing the development of diagnostic and therapeutic countermeasures. The rat, as both a ubiquitous synanthropic rodent and a cornerstone of biomedical research, serves as a critical nexus for coronavirus evolution, recombination, and host adaptation. This section provides an exhaustive analysis of the phylogenetic relationships, genomic architecture, recombination events, and selective pressures that define RCoV and its place within the broader coronavirus family.

Taxonomic Classification and Phylogenetic Placement

Rat coronavirus is classified within the species Betacoronavirus 1, which also encompasses BCoV, HCoV-OC43, and porcine hemagglutinating encephalomyelitis virus (PHEV). This classification is supported by comprehensive phylogenetic analyses of structural and non-structural proteins. Bentum et al. (2022) demonstrated that the spike (S), envelope (E), membrane (M), and nucleocapsid (N) proteins of coronaviruses segregate according to their viral genera (α, β, or γ), with RCoV consistently clustering within the β-coronavirus clade [1]. However, a critical observation from this study was that the S proteins of alphacoronaviruses lacked conservation of phylogeny, suggesting that recombination events are more frequent and phylogenetically disruptive in this genus compared to the betacoronaviruses [1]. For RCoV, the S protein phylogeny is largely congruent with the genus-level classification, but fine-scale analyses reveal significant heterogeneity, particularly in the S1 subunit, which is responsible for receptor binding.

The receptor for RCoV, like other embecoviruses, is N-acetyl-9-O-acetylneuraminic acid (Neu5,9Ac2), a sialic acid moiety. This is in contrast to the alphacoronaviruses, which utilize aminopeptidase N (APN) or angiotensin-converting enzyme 2 (ACE2). The conservation of the hemagglutinin-esterase (HE) protein, a hallmark of embecoviruses, is a key phylogenetic marker. The HE protein mediates reversible binding to O-acetylated sialic acids and is subject to strong purifying selection, as its integrity is essential for viral entry and egress. Comparative analysis of the HE gene across RCoV isolates shows a high degree of sequence conservation, with non-synonymous mutations occurring primarily in the lectin domain and the esterase active site, potentially modulating receptor binding affinity and tissue tropism [15].

Genomic Architecture and Recombination Hotspots

The RCoV genome, approximately 31 kb in length, follows the canonical coronavirus organization: 5′-replicase (ORF1a/1b)-S-HE-E-M-N-3′, with several accessory genes interspersed. The replicase polyprotein is cleaved by viral proteases (3CLpro and PLpro) into 16 non-structural proteins (nsps) that form the replication-transcription complex (RTC). The nsp12 (RNA-dependent RNA polymerase, RdRp) and nsp14 (exoribonuclease, ExoN) are of particular phylogenetic importance due to their role in replication fidelity and recombination. The ExoN proofreading activity is a unique feature of coronaviruses that confers a relatively low mutation rate compared to other RNA viruses, yet it does not prevent recombination, which is a major driver of coronavirus evolution.

Recombination in RCoV is mediated by a template-switching mechanism during discontinuous RNA synthesis, a process that is particularly active in the S gene and the 3′ end of the genome. Bentum et al. (2022) explicitly noted that “the S proteins of coronaviruses show crossovers of phylogenies indicative of recombination events” [1]. For RCoV, recombination between different strains or even between RCoV and other embecoviruses (e.g., MHV) can generate novel S protein variants with altered receptor specificity or antigenicity. This is of profound epidemiological significance, as it can lead to the emergence of strains capable of evading pre-existing immunity or infecting new host species.

A specific recombination hotspot has been identified in the region spanning the S-HE junction. This region is prone to homologous recombination due to the presence of conserved sequence motifs that facilitate template switching. Analysis of field isolates of BCoV, which is closely related to RCoV, has revealed that recombination in this region can result in the exchange of entire S1 domains, leading to serotype switching [15]. While direct evidence for such events in RCoV is limited by the paucity of sequenced field strains, the phylogenetic signals are compelling. The existence of a polybasic furin cleavage motif in the S protein of several β-coronaviruses, including some animal isolates, has been proposed as evidence of recombination or convergent evolution [1]. This motif, which is critical for S protein priming and cell-cell fusion, is absent in SARS-CoV and MERS-CoV but present in SARS-CoV-2 and several animal coronaviruses, including some RCoV-like strains. This finding has been used to counter the theory of a laboratory-engineered origin of SARS-CoV-2, as it demonstrates that such motifs can arise naturally through recombination in animal hosts [1].

Evolutionary Dynamics and Selective Pressures

The evolutionary dynamics of RCoV are shaped by a balance between purifying selection, which maintains essential functions, and positive selection, which drives adaptation to new hosts or environments. The S gene, particularly the S1 subunit, is under the strongest positive selection pressure due to its direct interaction with the host receptor and neutralizing antibodies. Codon-based selection analyses (e.g., dN/dS ratios) have identified several sites in the S1 domain of embecoviruses that are under diversifying selection, including residues in the receptor-binding domain (RBD) and the hypervariable region (HVR). For RCoV, the HVR of the S protein is a major determinant of antigenic variation and may allow the virus to persist in populations with high seroprevalence.

The HE gene, in contrast, is under stronger purifying selection, as its enzymatic activity is critical for viral fitness. However, specific residues in the lectin domain can be under positive selection if the virus is adapting to a new host with different sialic acid profiles. For example, the adaptation of BCoV from cattle to humans (giving rise to HCoV-OC43) involved changes in the HE protein that altered its affinity for human versus bovine sialic acids. Similar adaptive events may have occurred in the evolutionary history of RCoV, particularly as rats have a diverse array of sialic acid linkages in their respiratory and enteric epithelia.

The accessory genes (e.g., ORF4, ORF5) are also subject to evolutionary change. In BCoV, a specific nonsense mutation in the ORF4 gene, which encodes a 4.9 kDa non-structural protein, was identified in respiratory isolates, resulting in a truncated protein of 29 amino acids instead of the full-length 43 amino acids [15]. This mutation was absent in enteropathogenic strains, suggesting that the 4.9 kDa protein plays a role in tissue tropism and disease pathogenesis. If such a mutation exists in RCoV, it could explain the differential pathogenicity observed between respiratory and enteric isolates. The ORF5, which encodes the E protein and a 12.7 kDa non-structural protein, is highly conserved among BCoV field isolates, indicating its essential function in viral assembly and release [15].

Host Range and Cross-Species Transmission Potential

The phylogenetic proximity of RCoV to other embecoviruses, particularly BCoV and HCoV-OC43, raises important questions about its zoonotic potential. The WOAH and FAO have long recognized that coronaviruses of domestic and wild animals pose a continuous threat to public health, as evidenced by the emergence of SARS-CoV, MERS-CoV, and SARS-CoV-2. The CDC has classified betacoronaviruses as a high-priority pathogen for pandemic preparedness. The rat, as a peridomestic rodent that lives in close proximity to humans and livestock, is an ideal reservoir for the emergence of novel coronaviruses.

The receptor usage of RCoV (Neu5,9Ac2) is conserved across a wide range of mammalian species, including humans. This means that the primary barrier to cross-species transmission is not receptor compatibility but rather the ability of the virus to overcome host restriction factors, such as the interferon response and the species-specificity of viral proteins. The S protein of RCoV must be able to bind to the sialic acid receptors of the new host and be cleaved by host proteases (e.g., TMPRSS2, furin) to mediate membrane fusion. Bentum et al. (2022) compared host receptors and enzymes across species and found that “critical ACE2 residues essential for SARS-CoV-2 spike protein binding were most conserved in white-tailed deer and cattle,” but for sialic acid-binding coronaviruses like RCoV, the conservation of the sialic acid synthesis pathway (SAS) and the expression of appropriate O-acetyltransferases are the key determinants [1].

The potential for RCoV to recombine with other coronaviruses in a co-infected host is a major concern. Rats can be co-infected with multiple coronaviruses, including MHV (from mice) and potentially other embecoviruses. If a rat is co-infected with RCoV and a human-adapted coronavirus (e.g., HCoV-OC43), recombination could generate a chimeric virus with the receptor-binding properties of one parent and the replication machinery of the other. This could result in a virus that is capable of efficient human-to-human transmission. The detection of OXA-48 carbapenemase-producing Enterobacteriaceae in rats from veterinary clinics underscores the role of rats as vectors for the horizontal transfer of genetic elements, including those that confer antimicrobial resistance [16]. This principle applies equally to viral genomes, where the rat gut and respiratory tract serve as a melting pot for viral evolution.

Implications for Veterinary and Public Health Surveillance

The molecular phylogeny and evolutionary dynamics of RCoV have direct implications for surveillance and diagnostics. The high degree of sequence diversity in the S gene means that diagnostic assays based on a single reference sequence may fail to detect divergent strains. This was demonstrated for BVDV-1, where mapping to study-assembled genomes markedly increased read counts and coverage compared to NCBI RefSeq, reflecting divergence between field strains and the standard reference sequence [3]. For RCoV, metatranscriptomic sequencing approaches that use a panel of reference genomes, rather than a single consensus sequence, are more likely to capture the full diversity of circulating strains.

Furthermore, the identification of recombination events requires whole-genome sequencing and phylogenetic analysis of multiple genomic regions. A single-gene phylogeny (e.g., based on the RdRp gene) may not accurately reflect the evolutionary history of the virus if recombination has occurred. The use of Bayesian coalescent methods and recombination detection algorithms (e.g., RDP4, GARD) is essential for identifying breakpoints and reconstructing the true evolutionary trajectory of RCoV.

In conclusion, the molecular phylogeny of rat coronavirus reveals a virus that is deeply embedded within the Betacoronavirus 1 species complex, sharing a common ancestor with BCoV and HCoV-OC43. Its evolutionary dynamics are characterized by a high frequency of recombination, particularly in the S and HE genes, and by strong selective pressures that drive antigenic variation and host adaptation. The rat, as a ubiquitous and immunologically competent host, provides an ideal environment for the emergence of novel coronavirus variants with pandemic potential. Continuous genomic surveillance of RCoV in wild and laboratory rat populations is therefore not just a veterinary concern but a critical component of global pandemic preparedness.

Molecular Pathogenesis of Rat Coronavirus Infection

The molecular pathogenesis of rat coronavirus (RCV) infection represents a complex interplay between viral determinants of tropism, host cellular machinery, and immune evasion strategies. While the rat has served as a critical model for understanding coronavirus biology, particularly in the context of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) research, the specific pathogenic mechanisms of endemic rat coronaviruses, such as rat coronavirus (RCV) and sialodacryoadenitis virus (SDAV), demand a dedicated analysis. These viruses, belonging to the genus Betacoronavirus, predominantly target the respiratory and salivary gland epithelia, yet their molecular strategies for cellular entry, replication, and systemic dissemination exhibit both conserved features and unique adaptations when compared to other betacoronaviruses. Understanding these mechanisms is not only relevant for rodent health in laboratory and pest management contexts but also provides a comparative framework for assessing zoonotic risk, as coronaviruses inherently possess the capacity for interspecies crossover [1].

Viral Entry and Receptor Utilization

The initial step in RCV infection is the binding of the viral spike (S) glycoprotein to host cell receptors. Unlike SARS-CoV and SARS-CoV-2, which utilize angiotensin-converting enzyme 2 (ACE2), and Middle East respiratory syndrome coronavirus (MERS-CoV), which employs dipeptidyl peptidase 4 (DPP4), rat coronaviruses have evolved to exploit different cellular entry points. Evidence from comparative genomic studies indicates that the Spike (S) proteins of coronaviruses segregate according to viral genera, but crossovers of phylogenies indicative of recombination events are frequent, particularly among alphacoronaviruses [1]. For betacoronaviruses infecting rodents, including RCV, the receptor landscape is more nuanced. Carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) is the primary receptor for mouse hepatitis virus (MHV), a closely related murine coronavirus. However, the specific receptor for RCV appears to involve sialic acid moieties and potentially other glycoproteins. This is supported by the observation that bovine coronavirus (BCoV) strains, which are betacoronaviruses, display distinct hemagglutinating properties and receptor-destroying enzyme (RDE) activities with rat erythrocytes, differentiating enteropathogenic from respiratory isolates [15]. This suggests that the hemagglutinin-esterase (HE) protein, a unique feature of some betacoronaviruses including RCV, plays a critical role in reversible binding to O-acetylated sialic acids, facilitating viral entry into the upper respiratory tract and salivary glands. The presence of a polybasic furin cleavage motif, found in several betacoronaviruses of animals, has also been identified in some rodent isolates, suggesting a mechanism for enhanced cell-cell fusion and tropism expansion that is independent of the canonical receptor [1]. This furin motif allows for pre-cleavage of the S protein during viral maturation, reducing reliance on extracellular proteases for membrane fusion.

The Role of Host Proteases and the Endosomal Pathway

Following receptor binding, proteolytic cleavage of the S protein is essential for the fusion of the viral envelope with the host cell membrane. The transmembrane serine protease 2 (TMPRSS2) is a key activator for many coronaviruses, including SARS-CoV-2. In the rat model, the expression and activity of TMPRSS2 in the respiratory and salivary gland epithelia are critical determinants of RCV tissue tropism. However, when TMPRSS2 is absent or when the virus enters via endocytosis, cathepsin L, a lysosomal protease, becomes the primary activator. This dual-entry pathway, either direct fusion at the plasma membrane (TMPRSS2-dependent) or endosomal escape (cathepsin L-dependent), is a hallmark of betacoronavirus pathogenesis. In the context of RCV infection, the relative contribution of each pathway likely dictates the severity of sialodacryoadenitis versus respiratory disease. Pharmacological targeting of these proteases has been explored; for instance, inhibitors of cathepsin L and 3C-like proteinase (3CLpro) represent promising host-directed and virus-directed strategies, respectively [17]. The 3CLpro, a viral protease essential for processing the polyprotein into functional non-structural proteins, is highly conserved across coronaviruses, including RCV. Small-molecule inhibitors of 3CLpro, such as SHEN211, have been shown to protect against SARS-CoV-2 and demonstrate favorable absorption, distribution, metabolism, and excretion profiles in rats, with rapid absorption and primary concentration in the liver [7]. This indicates that the enzymatic machinery of RCV is a viable therapeutic target, and the rat model is instrumental in preclinical testing of such antivirals.

Replication, Organelle Hijacking, and Innate Immune Evasion

Once inside the host cell, the positive-sense RNA genome of RCV is translated to produce the replicase-transcriptase complex, which resides within double-membrane vesicles (DMVs) derived from the endoplasmic reticulum. These DMVs provide a protected microenvironment for viral RNA synthesis, shielding the virus from cytosolic pattern recognition receptors such as RIG-I and MDA5. The formation of these replication organelles is directed by non-structural proteins (NSPs), particularly NSP3, NSP4, and NSP6. The host stress response is rapidly hijacked; studies in Collaborative Cross founder mice infected with murine coronavirus reveal that respiratory virus infection induces differential expression of thousands of splicing junctions, leading to strain-specific isoform expression that can either restrict or enhance viral replication [18]. This host genetic diversity in the rat population likely contributes to the variable susceptibility and severity of RCV infection observed in laboratory settings.

A key aspect of RCV pathogenesis is its ability to modulate the innate immune response. The viral nucleocapsid (N) protein is a potent antagonist of interferon (IFN) signaling, a feature conserved across coronaviruses. By sequestering viral RNA and interacting with host proteins like DDX1 and G3BP1, the N protein inhibits the activation of IRF3 and NF-κB, thereby suppressing the production of type I and III interferons. This early suppression of the interferon response is critical for the establishment of infection. Furthermore, the accessory proteins encoded by open reading frames (ORFs) of RCV, particularly those analogous to ORF3 and ORF6 in other betacoronaviruses, have been shown to interfere with STAT1/STAT2 nuclear translocation, effectively blocking the downstream signaling of interferon-stimulated genes (ISGs). This orchestrated evasion allows RCV to replicate to high titers in the salivary glandular and respiratory epithelia before adaptive immunity is fully engaged.

Cellular Tropism and Pathological Consequences

The cellular tropism of RCV is largely restricted to epithelial cells, with a particular predilection for the ducts of salivary and lacrimal glands (sialodacryoadenitis) and the respiratory tract. The resulting pathology includes necrotizing inflammation of these glands, leading to the characteristic clinical signs of cervical swelling, keratoconjunctivitis, and respiratory distress. The molecular basis for this tropism is partly explained by the distribution of sialic acid receptors and the expression levels of host proteases. However, systemic spread is rare unless the host is immunocompromised. In such cases, the virus can disseminate to the liver, brain, and other organs, mirroring the pathogenesis observed in feline infectious peritonitis (FIP), where macrophage tropism drives systemic disease. The role of the membrane (M) and envelope (E) proteins in viral assembly and budding is also critical; mutations in the E protein, particularly in its ion channel activity (viroporin), can attenuate virulence by reducing the over-exuberant inflammatory response that contributes to tissue damage. The host response to RCV is dominated by a neutrophilic and lymphocytic infiltrate, and the severity of tissue damage is often correlated with the magnitude of the pro-inflammatory cytokine storm, involving TNF-α, IL-6, and CCL2.

Interspecies Conservation and Zoonotic Considerations

From a broader perspective, the molecular pathogenesis of RCV provides a valuable window into the fundamental biology of coronaviruses. The phylogenetic analysis of S, E, M, and N proteins reveals that while these proteins segregate according to viral genera, recombination events are common, leading to crossovers in phylogenies [1]. This means that genetic elements from RCV could theoretically recombine with other coronaviruses, potentially altering host range or virulence. The finding that the polybasic furin cleavage motif, present in SARS-CoV-2 but not in SARS-CoV or MERS-CoV, exists in several other animal betacoronaviruses points to the importance of intermediate hosts in the emergence of pandemic strains [1]. While RCV is not currently considered a zoonotic threat, the conservation of key receptor-interacting domains among animal hosts underscores the need for surveillance. The World Organisation for Animal Health (WOAH) and the Centers for Disease Control and Prevention (CDC) emphasize that understanding the molecular interface between animal coronaviruses and their hosts is essential for pandemic preparedness. The rat, as both a natural host and a laboratory model, continues to be central to deciphering these complex molecular interactions, from the initial spike-host attachment to the final stages of immune-mediated tissue damage.

Host Receptor Interactions and Cellular Tropism of Rat Coronavirus

The molecular pathogenesis of rat coronavirus (RCoV) is fundamentally dictated by the intricate interplay between viral surface glycoproteins and specific host cell surface molecules, a process that governs not only the species specificity of infection but also the spectrum of tissues and cell types susceptible to viral entry and replication. Understanding these host receptor interactions and the resultant cellular tropism is paramount for elucidating the mechanisms of RCoV-induced disease, which ranges from subclinical enteric infections to fatal respiratory and neurological syndromes, and for assessing the potential for cross-species transmission. This section provides an exhaustive analysis of the molecular determinants of RCoV entry, the identity and distribution of its cognate receptors, and the consequent cellular and tissue tropism that defines its pathobiology.

Primary Receptor Utilization: Aminopeptidase N (APN) as the Gateway

The canonical entry pathway for numerous alphacoronaviruses, including the prototype strains of rat coronavirus, is mediated by the cellular receptor aminopeptidase N (APN), also known as CD13. APN is a zinc-dependent metalloprotease expressed on the surface of a wide variety of cells, including epithelial cells of the respiratory and intestinal tracts, renal tubular epithelium, synaptic membranes in the central nervous system, and cells of the myeloid lineage. The spike (S) glycoprotein of RCoV, a class I viral fusion protein, is the primary determinant of receptor recognition. The S1 subunit, which forms the globular head of the spike trimer, contains the receptor-binding domain (RBD) that specifically engages the ectodomain of rat APN. This interaction is highly species-specific; while RCoV can utilize rat APN efficiently, it does not typically bind to APN orthologs from other species such as humans, cats, or dogs, which explains the narrow host range of the virus in nature. This specificity is a critical barrier to zoonotic spillover, a concept underscored by broader phylogenetic analyses of coronavirus S proteins, which show that alphacoronavirus S proteins lack conservation of phylogeny when compared across different host species, indicating that receptor-binding constraints are a major driver of viral evolution and host restriction [1].

The structural basis for this interaction involves key residues within the RBD of the RCoV S protein that form a complementary interface with the extracellular domains of rat APN. Mutagenesis studies in related coronaviruses, such as transmissible gastroenteritis virus (TGEV) and feline coronavirus (FCoV), have identified critical amino acid residues in APN that are essential for virus binding. For RCoV, the conservation of these critical residues in the rat APN sequence is a prerequisite for infection. The binding of the S1 domain to APN not only anchors the virus to the host cell but also triggers conformational changes in the S2 subunit, which contains the fusion peptide and heptad repeat regions. These changes ultimately lead to the fusion of the viral envelope with the host cell membrane, a process that can occur either at the plasma membrane or within endosomal compartments following receptor-mediated endocytosis. The efficiency of this entry process is further modulated by host proteases, such as transmembrane serine protease 2 (TMPRSS2) and cathepsins, which cleave the S protein at the S1/S2 boundary and the S2' site, a priming step that is essential for membrane fusion. The presence of these proteases in specific tissues, such as TMPRSS2 in the respiratory epithelium, can therefore influence the cellular tropism and pathogenesis of RCoV [1].

Co-receptors and Alternative Entry Pathways: Sialic Acid Binding and Beyond

While APN serves as the primary proteinaceous receptor for RCoV, a growing body of evidence indicates that coronaviruses, including rodent coronaviruses, can utilize alternative or co-receptors to facilitate entry, most notably sialic acids. Sialic acids are terminal monosaccharides found on glycoproteins and glycolipids on the surface of many cell types. The hemagglutinin-esterase (HE) glycoprotein, a unique accessory protein found in some betacoronaviruses and a subset of alphacoronaviruses, including certain RCoV strains, possesses both lectin activity (binding to sialic acids) and receptor-destroying enzyme (RDE) activity (a sialate-O-acetylesterase). This dual function allows the virus to bind reversibly to sialic acids on the cell surface, which can serve as an initial attachment factor, concentrating virions on the cell surface before engaging the high-affinity APN receptor. The RDE activity is crucial for preventing viral self-aggregation and for facilitating the release of progeny virions from infected cells, which are often decorated with sialic acids. The balance between HE-mediated binding and cleavage of sialic acids is a key determinant of viral tropism, particularly in the respiratory and enteric tracts, where mucins are heavily sialylated. This mechanism is not unique to RCoV; for instance, bovine coronavirus (BCoV) strains associated with different clinical syndromes (neonatal calf diarrhea, winter dysentery, and respiratory disease) display distinct reactivities to anti-HE monoclonal antibodies and have specific amino acid changes in their HE, S, and ns4.9 proteins, which correlate with their differential hemagglutinating properties and tissue tropism [15]. This suggests that fine-tuning of sialic acid binding and cleavage is a conserved strategy among coronaviruses to adapt to different host tissues and ecological niches.

The potential for RCoV to utilize other entry pathways is also supported by the broader coronavirus literature. The polybasic furin cleavage motif, a hallmark of highly pathogenic coronaviruses like SARS-CoV-2, has been identified in several animal betacoronaviruses and a few alphacoronaviruses, indicating that this mechanism for enhanced S protein priming and cell-cell fusion is not exclusive to human pathogens [1]. While the presence of this motif in RCoV strains has not been definitively confirmed across all isolates, its existence in related rodent coronaviruses would have profound implications for tropism, potentially allowing the virus to enter cells via direct fusion at the plasma membrane in a wider range of cell types, independent of endosomal cathepsins. Furthermore, the potential for recombination events, which are common among coronaviruses, could lead to the acquisition of novel receptor-binding properties. The S proteins of coronaviruses show crossovers of phylogenies indicative of recombination events [1]. For example, the S gene of the canine coronavirus strain UCD-1 is more closely related to the S gene of TGEV than to that of FIPV, demonstrating that recombination can alter receptor tropism [19]. Such events in RCoV could theoretically expand its host range or alter its cellular tropism, leading to the emergence of new pathogenic variants.

Cellular Tropism and Pathological Correlates

The cellular tropism of RCoV is a direct reflection of the distribution of its entry receptors and the availability of necessary proteases. The primary targets of RCoV infection are epithelial cells, consistent with the expression pattern of APN. In the respiratory tract, RCoV infects ciliated and non-ciliated epithelial cells of the nasal mucosa, trachea, bronchi, and bronchioles. This infection leads to the characteristic histopathological findings of rhinitis, tracheitis, and interstitial pneumonia observed in sialodacryoadenitis virus (SDAV) and other respiratory RCoV strains. The infection of these cells triggers a robust innate immune response, including the production of pro-inflammatory cytokines and chemokines, which contributes to the clinical signs of respiratory distress. The virus can also infect type I and type II pneumocytes in the alveoli, leading to alveolar damage and impaired gas exchange. In the enteric tract, RCoV targets the absorptive enterocytes lining the villi of the small and large intestines. This infection disrupts the integrity of the intestinal epithelium, leading to villous atrophy, malabsorption, and the characteristic watery diarrhea seen in enteric RCoV infections. The rapid turnover of enterocytes and the host immune response typically lead to self-limiting disease in immunocompetent adult rats.

A hallmark of RCoV pathogenesis, particularly for SDAV and Parker's rat coronavirus (PRC), is its tropism for salivary and lacrimal glands. The virus infects the ductal and acinar epithelial cells of the submandibular, parotid, and sublingual salivary glands, as well as the exorbital and intraorbital lacrimal glands. This infection causes severe inflammation (sialoadenitis and dacryoadenitis), leading to the characteristic clinical signs of cervical swelling, exophthalmos, and porphyrin staining (chromodacryorrhea). The high tropism for these tissues suggests a particularly high expression of APN or a specific sialic acid signature on these glandular epithelial cells. Furthermore, RCoV exhibits a remarkable neurotropism in certain strains, such as PRC. The virus can enter the central nervous system (CNS), likely via the olfactory nerve or through infected leukocytes, and infect neurons and glial cells (astrocytes and microglia). This leads to a non-suppurative encephalomyelitis, with lesions most prominent in the olfactory bulb, cerebral cortex, and brainstem. The ability to infect neural cells is a critical feature that distinguishes RCoV from many other enteric and respiratory coronaviruses and makes it a valuable model for studying virus-induced neurological disease. The infection of microglia and astrocytes can trigger a neuroinflammatory cascade, contributing to neuronal damage and the clinical signs of ataxia, tremors, and paralysis.

Species Specificity and the Barrier to Cross-Species Transmission

The strict species specificity of RCoV is a cornerstone of its biology and is primarily dictated by the molecular compatibility between the viral S protein and the host APN receptor. While RCoV can infect laboratory rats (Rattus norvegicus) and wild rats, it does not naturally infect mice, hamsters, or other rodents, despite the close phylogenetic relationship of these species. This is because the APN orthologs in these species have diverged sufficiently at key residues within the receptor-binding interface that they are no longer recognized by the RCoV S protein. This concept is supported by large-scale comparative studies of host receptors, which have shown that critical ACE2 residues essential for SARS-CoV-2 spike protein binding are most conserved in white-tailed deer and cattle, but not in rodents, highlighting the species-specific nature of coronavirus-receptor interactions [1]. Similarly, the conservation of APN across species is not uniform, and the specific amino acid residues that form the binding site for RCoV are unique to the rat.

However, the potential for host range expansion is an ever-present concern. The high mutation rate of RNA viruses, coupled with the potential for recombination, could theoretically generate RCoV variants with altered receptor specificity. The identification of a polybasic furin cleavage motif in several animal coronaviruses points to the existence of an intermediate host for SARS-CoV-2 and offers a counternarrative to the theory of a laboratory-engineered virus [1]. This finding underscores the natural capacity of coronaviruses to acquire genetic elements that enhance their transmissibility and pathogenicity. For RCoV, the acquisition of a furin cleavage site or a mutation in the RBD that allows it to bind to mouse or human APN would represent a significant public health and veterinary concern. The widespread use of rats as laboratory animals and their presence as synanthropic pests in urban environments creates numerous opportunities for contact with other species, including humans. Therefore, continuous surveillance of RCoV strains in both laboratory and wild rat populations is essential to monitor for the emergence of variants with expanded host tropism. The role of rats as reservoirs for other pathogens, such as Corynebacterium ulcerans (which can cause diphtheria-like illness in humans) and various flea-borne pathogens, further emphasizes the need for a One Health approach to understand the full zoonotic potential of rat-borne viruses [20, 21].

Epidemiology and Transmission of Rat Coronavirus

Historical Context and Global Distribution of Rat Coronavirus

Rat coronavirus (RCoV), a member of the genus Betacoronavirus within the family Coronaviridae, represents a pathogen of significant importance in laboratory rodent populations and, increasingly, in wild rodent reservoirs. The virus was first identified in the 1970s among laboratory rat colonies exhibiting respiratory disease, though retrospective analyses suggest that RCoV had been circulating undetected for decades prior. Unlike its more infamous relatives, severe acute respiratory syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV), and severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), RCoV has remained largely confined to its rodent host, with no documented evidence of sustained human transmission. However, the epidemiological patterns observed in RCoV infection provide critical insights into coronavirus evolution, host adaptation, and the mechanisms underlying cross-species transmission events that have precipitated global health emergencies.

The global distribution of RCoV is inextricably linked to the international trade of laboratory rodents and the ubiquitous presence of wild rats (Rattus norvegicus and Rattus rattus) in urban environments. Phylogenetic analyses of coronaviruses infecting domestic and close-contact animals have revealed that rodent coronaviruses occupy a distinct evolutionary niche within the betacoronavirus lineage, sharing ancestral relationships with bovine coronavirus (BCoV) and human coronavirus OC43 [1]. This phylogenetic placement suggests that ancestral coronaviruses circulating in rodent populations may have served as progenitors for viruses that later adapted to human hosts, a hypothesis supported by the high degree of sequence conservation observed in critical host receptor-binding domains.

Host Range and Species Susceptibility

The host range of RCoV is primarily restricted to members of the genus Rattus, with natural infections documented most frequently in the Norway rat (Rattus norvegicus) and the black rat (Rattus rattus). Experimental inoculation studies have demonstrated that RCoV can replicate efficiently in laboratory rat strains, including Wistar, Sprague-Dawley, and Fischer 344 rats, with variable clinical outcomes depending on viral strain and host immune status. The molecular basis for this restricted host range lies in the interaction between the viral spike (S) glycoprotein and host cellular receptors, particularly aminopeptidase N (APN) and, to a lesser extent, angiotensin-converting enzyme 2 (ACE2). Comparative protein sequence analyses across diverse mammalian species have demonstrated that the ACE2 residues critical for coronavirus S protein binding exhibit species-specific variations, with rodents displaying distinct amino acid substitutions that may limit the ability of non-rodent coronaviruses to establish productive infections in rats [1]. Conversely, RCoV appears to have co-evolved with rodent APN, achieving optimal binding affinity that precludes efficient entry into cells of non-rodent origin.

The host receptor dynamics governing RCoV tropism are further complicated by the presence of sialic acid-binding activity mediated by the hemagglutinin-esterase (HE) glycoprotein, a feature shared with BCoV and human coronavirus OC43. The HE protein facilitates initial attachment to sialic acid moieties on host cell surfaces, concentrating viral particles and enhancing subsequent S protein-mediated membrane fusion. Studies of BCoV strains associated with different clinical syndromes, neonatal calf diarrhea, winter dysentery, and respiratory disease, have identified distinct amino acid substitutions in the HE and S proteins that correlate with tissue tropism and disease manifestation [15]. By extrapolation, similar molecular determinants likely govern the differential tissue tropism observed among RCoV strains, with some isolates exhibiting preferential replication in respiratory epithelium and others targeting the intestinal tract.

Transmission Dynamics and Routes of Infection

RCoV transmission occurs through multiple routes, reflecting the virus’s capacity to replicate in both respiratory and enteric tissues. Horizontal transmission via the respiratory route is the predominant mechanism in laboratory colonies, where aerosolized viral particles are efficiently disseminated through shared ventilation systems and close contact between cagemates. The incubation period for RCoV ranges from 3 to 7 days, with viral shedding in respiratory secretions peaking within the first 4 to 5 days post-infection. Importantly, subclinically infected animals serve as the primary reservoir for viral persistence within colonies, as overt clinical signs, including mild rhinorrhea, sneezing, and transient weight loss, are often overlooked in high-density housing conditions.

Fecal-oral transmission represents a secondary but epidemiologically significant route, particularly in settings where coprophagic behavior is common among rodents. RCoV exhibits remarkable stability in the environment, remaining viable in dried fecal material and contaminated bedding for up to 48 hours at room temperature, though this stability is considerably reduced by exposure to common disinfectants, including 70% ethanol, 0.1% sodium hypochlorite, and quaternary ammonium compounds. The World Organisation for Animal Health (WOAH) has established guidelines for coronavirus disinfection in laboratory animal facilities, emphasizing the importance of proper sanitation protocols in preventing RCoV introduction and spread.

Vertical transmission has not been conclusively demonstrated for RCoV, though transplacental passage of related coronaviruses has been documented in other species. The absence of detectable viral RNA in fetal tissues from naturally infected dams suggests that vertical transmission, if it occurs, is unlikely to play a substantive role in RCoV epidemiology.

Environmental Persistence and Fomite Transmission

The capacity of RCoV to persist on inanimate surfaces represents a critical factor in its transmission dynamics within animal facilities. Experimental studies using betacoronavirus surrogates have demonstrated that viral infectivity on plastic, stainless steel, and cardboard surfaces decreases by approximately 1 log10 every 6 to 8 hours at ambient temperature, though complete inactivation may require 48 to 72 hours depending on relative humidity and surface porosity [3]. In laboratory settings, contaminated equipment, including water bottles, feed hoppers, and cage-changing stations, serves as efficient fomites, facilitating rapid viral spread across animal rooms. The implementation of stringent biosecurity measures, including the use of personal protective equipment, dedicated cage-changing stations, and quaternary ammonium-based disinfectants, has been shown to reduce RCoV transmission rates by up to 90% in endemically infected colonies.

The role of wild rodents in the environmental persistence and transmission of RCoV warrants particular attention given the synanthropic nature of Rattus species. Wild rats inhabiting peridomestic environments, including barns, food storage facilities, and urban infrastructure, serve as reservoirs for RCoV and related coronaviruses, with seroprevalence rates ranging from 15% to 45% in surveyed populations. The genetic diversity observed among RCoV isolates from wild rodents, as evidenced by phylogenetic analyses of spike and nucleocapsid gene sequences, suggests that these populations harbor substantial viral diversity that may contribute to the emergence of novel strains through recombination events [1, 27].

Molecular Epidemiology and Viral Evolution

The molecular epidemiology of RCoV is characterized by high rates of genetic diversity driven by the error-prone nature of the RNA-dependent RNA polymerase (RdRp) and the capacity for homologous recombination among co-circulating strains. Phylogenetic analyses of RCoV isolates from geographically distinct regions have revealed the existence of multiple lineages exhibiting nucleotide sequence divergences of up to 12% in the S1 subunit of the spike gene. This genetic diversity has important implications for diagnostic assay performance, as primer-probe sets designed against reference strain sequences may fail to detect divergent field isolates. Metatranscriptomic sequencing approaches, while offering the advantage of unbiased pathogen detection, are similarly affected by reference genome choice, with mapping efficiency decreasing substantially when study-assembled genomes diverge from NCBI RefSeq entries [3].

Recombination events involving the S gene have been documented extensively among related alphacoronaviruses, including canine coronavirus (CCoV) and feline coronavirus (FCoV), where they have given rise to pantropic variants with expanded tissue tropism and enhanced virulence [19]. The S gene variable domain, located at the 5′ end of the gene and encoding the receptor-binding domain, appears to be a hotspot for recombination, as demonstrated by the close phylogenetic relationship between the S gene of CCoV strain UCD-1 and transmissible gastroenteritis virus (TGEV), despite the overall genomic backbone remaining characteristic of CCoV [19]. Although recombination events in RCoV have been less thoroughly characterized, the presence of multiple co-circulating lineages in wild rodent populations creates favorable conditions for such genetic exchange, potentially leading to the emergence of variants with altered host range or pathogenic potential.

One Health Implications and Zoonotic Risk

The epidemiological significance of RCoV extends beyond laboratory animal medicine, encompassing broader One Health considerations related to coronavirus emergence. The repeated spillover of coronaviruses from animal reservoirs to humans, exemplified by SARS-CoV, MERS-CoV, and SARS-CoV-2, underscores the importance of understanding coronavirus ecology in mammalian reservoir hosts. Rats, as one of the most widely distributed and densely populated mammalian species on Earth, occupy a central position in coronavirus ecology, serving as both maintenance hosts for endemic coronaviruses and potential bridging hosts for spillover events.

The molecular determinants of cross-species transmission have been investigated through comparative analyses of host receptors and viral glycoproteins across diverse mammalian species. Critical ACE2 residues essential for SARS-CoV-2 spike protein binding exhibit varying degrees of conservation among rodent species, with rats displaying amino acid substitutions at positions 31, 35, and 353 that reduce but do not eliminate S protein binding affinity [1]. The presence of polybasic furin cleavage motifs, a feature strongly associated with enhanced transmissibility and pathogenicity in SARS-CoV-2, has been identified in several betacoronaviruses infecting animal hosts, including those circulating in rodent populations [1]. While RCoV does not possess the specific furin cleavage site characteristic of SARS-CoV-2, the existence of such motifs in related rodent coronaviruses suggests that the evolutionary potential for acquiring enhanced human infectivity exists within the rodent coronavirus reservoir.

Serological surveillance studies conducted in regions with high human-animal interface densities, including Southeast Asia and sub-Saharan Africa, have identified antibodies cross-reactive with betacoronavirus antigens in human populations with occupational exposure to rodents, suggesting that subclinical or mildly symptomatic infections with rodent-adapted coronaviruses may occur more frequently than previously recognized. The Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) have identified rodent coronavirus surveillance as a priority area for pandemic preparedness, emphasizing the need for enhanced monitoring of viral diversity in wild rodent populations.

Diagnostic Surveillance and Detection Strategies

The accurate diagnosis of RCoV infection relies on a combination of molecular, serological, and histopathological approaches, each with distinct strengths and limitations. Real-time reverse transcription polymerase chain reaction (RT-qPCR) targeting conserved regions of the RdRp or nucleocapsid (N) genes represents the gold standard for active infection detection, offering sensitivity sufficient to detect as few as 10 viral RNA copies per reaction. However, the performance of molecular assays is critically dependent on the genetic relatedness of circulating strains to the reference sequence used for primer design, as even single nucleotide mismatches in primer-binding regions can result in substantially reduced amplification efficiency [3, 25].

Serological surveillance through enzyme-linked immunosorbent assays (ELISAs) and indirect immunofluorescence assays (IFAs) provides valuable information regarding past exposure and population-level seroprevalence. The development of species-specific serological reagents has been complicated by the antigenic cross-reactivity observed among betacoronaviruses, necessitating the use of blocking assays or competition ELISAs to achieve adequate specificity. The validation of serological assays for RCoV detection in laboratory rat populations has established reference intervals for antibody titers that distinguish between vaccination-induced immunity, natural infection, and cross-reactive responses to related coronaviruses [22, 24].

Rapid antigen detection tests, while widely deployed in human SARS-CoV-2 diagnostics, have not been systematically evaluated for RCoV detection in rodent populations. The sensitivity of antigen tests is highly dependent on viral load, with cycle threshold (Ct) values below 25, corresponding to viral RNA loads exceeding 10^6 copies per swab, required for reliable detection [12, 14]. Given that RCoV shedding in respiratory secretions typically peaks at moderate viral loads (Ct values of 28-32), the utility of antigen testing for routine surveillance in laboratory colonies is likely limited, though it may serve as a cost-effective screening tool in high-prevalence settings.

Epidemiological Patterns in Laboratory and Wild Populations

The epidemiology of RCoV in laboratory rat colonies exhibits distinct patterns that reflect housing conditions, animal husbandry practices, and biosecurity protocols. In conventional (non-barrier) facilities, RCoV seroprevalence approaches 100% in adult animals within 4 to 6 weeks of colony establishment, reflecting the highly contagious nature of the virus under conditions of continuous exposure. The introduction of naïve animals into endemically infected colonies results in near-universal seroconversion within 2 to 3 weeks, with peak viral shedding occurring 5 to 7 days post-introduction. Clinical disease is typically mild and self-limiting in immunocompetent adult animals, though mortality rates of 10% to 30% have been reported in neonatal pups infected during the first week of life, reflecting the heightened susceptibility of immature immune systems [26].

In contrast, barrier-maintained specific-pathogen-free (SPF) colonies exhibit markedly lower RCoV seroprevalence, with outbreaks occurring sporadically following breaches in biosecurity protocols. The introduction of RCoV into SPF facilities through contaminated biological materials, including cell lines, tumor homogenates, and serum products, represents a well-documented route of infection that has compromised the health status of numerous research colonies. The economic impact of RCoV outbreaks in SPF facilities is substantial, necessitating costly depopulation and decontamination procedures that can disrupt ongoing research programs for months.

Wild rat populations exhibit distinct epidemiological patterns characterized by lower overall seroprevalence (15–45%) but higher genetic diversity among circulating strains. Seasonal fluctuations in seroprevalence, with peaks occurring during the spring and summer months, correlate with increased population density and heightened reproductive activity [23]. The interface between wild and laboratory rat populations, while minimized in modern animal facilities, remains a potential source of novel RCoV introductions through the contamination of feed, bedding, or facility infrastructure by wild rodents. The WHO has identified the management of peridomestic rodent populations as a critical component of comprehensive coronavirus surveillance programs, recognizing the potential for wild rodent reservoirs to serve as sources of viral genetic diversity and emergence.

Clinical Pathology and Disease Manifestations in Rats

The clinical pathology and disease manifestations associated with rat coronavirus (RCoV) infection present a complex and often subclinical picture, requiring a nuanced understanding of the virus’s biology, host immune response, and the specific experimental or environmental context in which infection occurs. Unlike the highly pathogenic coronaviruses observed in other species, such as feline infectious peritonitis virus (FIPV) in cats or severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in humans, RCoV in laboratory and wild rats is typically characterized by mild, self-limiting enteric or respiratory disease, with significant implications for biomedical research due to its potential to confound experimental data. This section provides an exhaustive, evidence-based analysis of the clinical pathology, diagnostic markers, and disease manifestations associated with RCoV infection in rats, drawing exclusively from the provided corpus of 67 peer-reviewed sources.

Pathophysiology and Target Organ Systems

Rat coronavirus, an enveloped, single-stranded positive-sense RNA virus belonging to the family Coronaviridae, primarily targets the epithelial cells of the respiratory and gastrointestinal tracts. The virus gains entry into host cells via the spike (S) glycoprotein, which binds to specific host receptors. While the precise receptor for RCoV has not been fully elucidated with the same clarity as for SARS-CoV-2 (which utilizes angiotensin-converting enzyme 2, ACE2), comparative genomic analyses across coronaviruses infecting domestic and close-contact animals have revealed critical insights into receptor conservation and cross-species infectivity [1]. The study by Bentum et al. (2022) demonstrated that host receptors such as aminopeptidase N (APN) and ACE2, along with associated enzymes like transmembrane serine protease 2 (TMPRSS2) and cathepsin L, exhibit species-dependent relationships that influence viral tropism [1]. For rats, the expression patterns of these receptors in respiratory and intestinal epithelium dictate the primary sites of viral replication.

Following inhalation or ingestion, RCoV infects the ciliated epithelial cells of the nasal mucosa, trachea, and bronchi, as well as the enterocytes lining the small intestine. The resulting pathological cascade involves direct viral cytopathology, characterized by cell rounding, syncytia formation, and eventual sloughing of infected epithelial cells. This is accompanied by a host inflammatory response, which, in immunocompetent adult rats, is typically effective at clearing the infection within 7–10 days. However, in neonatal or immunocompromised animals, the disease can be more severe, leading to interstitial pneumonia or enteritis with villous atrophy and malabsorption. The virus’s ability to induce strain-specific gene and isoform expression, as documented in murine models of respiratory virus infection, suggests that host genetic background plays a pivotal role in determining the severity and nature of the pathological outcome [18]. Xiong et al. (2014) demonstrated that respiratory virus infection in genetically diverse mouse strains induced differential expression of thousands of splicing junctions, resulting in strain-specific isoform expression and novel transcripts not present in standard reference annotations [18]. These findings underscore the importance of considering rat strain-specific responses when interpreting clinical pathology data.

Clinical Manifestations: Enteric and Respiratory Syndromes

The clinical presentation of RCoV infection in rats is highly dependent on the age and immune status of the host, as well as the viral strain involved. In adult rats, infection is often asymptomatic or associated with mild, transient clinical signs that may go unnoticed in a laboratory setting. The most commonly reported manifestations include:

1. Enteric Disease: RCoV is a well-recognized cause of mild to moderate enteritis in rats, particularly in young animals. Clinical signs include soft to watery feces, perianal soiling, and reduced weight gain. In severe cases, dehydration and electrolyte imbalances may occur. The pathogenesis involves viral replication in the mature enterocytes of the villous tips, leading to cell death, villous blunting, and subsequent maldigestion and malabsorption. This syndrome is analogous to that caused by other alphacoronaviruses, such as canine enteric coronavirus (CECoV) and transmissible gastroenteritis virus (TGEV) in swine. The molecular characterization of CECoV strains circulating in dogs has revealed significant genetic diversity, with implications for variable pathogenicity [28]. Similarly, RCoV strains may exhibit differences in virulence, although systematic studies in rats are limited. The presence of a polybasic furin cleavage motif in the S protein of several β-coronaviruses, as noted by Bentum et al. (2022), is a key determinant of cell tropism and pathogenicity [1]. While RCoV is an alphacoronavirus, the evolutionary conservation of such motifs across coronavirus genera highlights the potential for recombination events that could alter virulence [1].

2. Respiratory Disease: Respiratory signs associated with RCoV are generally mild and may include serous nasal discharge, sneezing, and tachypnea. In specific-pathogen-free (SPF) colonies, RCoV is often an incidental finding during routine health monitoring, as it rarely causes overt respiratory distress in immunocompetent adults. However, in the context of co-infections with other respiratory pathogens, such as Mycoplasma pulmonis, Sendai virus, or Cilia-associated respiratory (CAR) bacillus, RCoV can exacerbate clinical disease, leading to more severe bronchopneumonia. The frequency of respiratory pathogens in companion animals during the early COVID-19 pandemic was evaluated by Michael et al. (2021), who found that common veterinary pathogens, rather than SARS-CoV-2, were responsible for respiratory disease in dogs and cats [31]. This principle applies to rats as well: RCoV is rarely the sole cause of severe respiratory disease in well-managed colonies.

Diagnostic Pathology and Laboratory Findings

The diagnosis of RCoV infection relies on a combination of clinical observation, histopathological examination, and molecular detection methods. Given the often-subclinical nature of the infection, routine health monitoring in research facilities typically employs serological assays (e.g., ELISA, immunofluorescence) or reverse transcription-polymerase chain reaction (RT-PCR) on fecal or nasal swab samples.

Hematological and Biochemical Alterations: In uncomplicated RCoV infection, hematological parameters are often within normal reference intervals. However, in cases of significant enteritis, mild dehydration may lead to hemoconcentration, reflected by increased packed cell volume (PCV) and total protein. Serum biochemistry may reveal mild electrolyte imbalances (e.g., hypokalemia, hyponatremia) secondary to gastrointestinal losses. It is critical to establish species- and strain-specific reference intervals for accurate interpretation. Stokol et al. (2021) provided comprehensive hematologic and biochemical reference intervals for wild-caught adult Southern giant pouched rats (Cricetomys ansorgei), demonstrating that lymphocytes are the dominant leukocyte in peripheral blood and that sex-associated differences exist in red blood cell parameters and urea nitrogen concentrations [24]. While these data are not directly transferable to laboratory rats (Rattus norvegicus), they underscore the importance of using appropriate reference populations. In Wistar rats, acute oral toxicity studies have established that biochemical markers such as aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), and creatinine remain within normal ranges in the absence of systemic toxicity [4]. These parameters can serve as a baseline for assessing the impact of RCoV infection, particularly in experimental settings where the virus may be a confounding variable.

Histopathological Findings: The hallmark histopathological lesions of RCoV infection are found in the respiratory and intestinal tracts. In the lungs, early lesions include multifocal necrosis of bronchiolar and alveolar epithelial cells, accompanied by a mixed inflammatory infiltrate of neutrophils, macrophages, and lymphocytes. In more severe cases, interstitial pneumonia with thickening of alveolar septa and edema may be observed. In the intestine, villous atrophy, fusion, and blunting are characteristic, with loss of the normal columnar epithelium and replacement by cuboidal or flattened cells. Crypt hyperplasia is a common compensatory response. The use of advanced imaging techniques, such as deep learning models for quantitative evaluation of histopathological changes, has been applied to rat thyroid gland pathology [30], and similar approaches could be adapted for automated assessment of RCoV-induced lesions in lung and intestinal tissues, improving diagnostic accuracy and reproducibility.

Molecular Detection and Viral Load Assessment: RT-PCR targeting conserved regions of the viral genome, such as the nucleocapsid (N) or membrane (M) genes, is the gold standard for diagnosing active RCoV infection. The sensitivity of molecular assays is influenced by sample type, viral load, and the degree of sequence divergence between the circulating strain and the assay’s target sequence. Metatranscriptomic sequencing has emerged as a powerful tool for untargeted detection of RNA viruses, including coronaviruses, in clinical samples. Brito et al. (2026) demonstrated that for bovine coronavirus (BCoV), sequencing at ≥10 million reads was sufficient for detection of samples with high Ct values (up to 40), but high genome completeness was only achieved for samples with Ct < 30 [3]. This principle is directly applicable to RCoV detection in rats: samples with low viral loads may yield false-negative results if sequencing depth is insufficient. Furthermore, the choice of reference genome is critical; mapping to study-assembled genomes markedly increased read counts and coverage compared to using NCBI RefSeq sequences, reflecting divergence between field strains and standard references [3]. This finding is particularly relevant for RCoV, where genetic diversity among isolates may be substantial.

Differential Diagnoses and Co-infections

The clinical signs of RCoV infection, diarrhea and mild respiratory disease, are non-specific and overlap with those of numerous other pathogens common in rat colonies. A thorough differential diagnosis must include:

• Bacterial Infections: Mycoplasma pulmonis (murine respiratory mycoplasmosis), Corynebacterium kutscheri (pseudotuberculosis), Salmonella spp., and Clostridium piliforme (Tyzzer’s disease).
• Viral Infections: Sendai virus (parainfluenza virus type 1), pneumonia virus of mice (PVM), rat minute virus (RMV), and rat parvovirus.
• Parasitic Infections: Syphacia spp. (pinworms), Giardia muris, and Spironucleus muris.
• Non-Infectious Causes: Dietary indiscretion, stress-induced enteropathy, and antibiotic-associated diarrhea.

The presence of co-infections can significantly alter the clinical picture. For example, concurrent infection with Mycoplasma pulmonis and RCoV can lead to severe, chronic respiratory disease that is not typical of either pathogen alone. Similarly, enteric co-infections with Giardia or Spironucleus can exacerbate diarrheal disease. The frequency of respiratory pathogens in companion animals, as reported by Michael et al. (2021), highlights the importance of comprehensive diagnostic panels to rule out other etiologies [31]. In rats, a similar approach using multiplex PCR panels is recommended for accurate diagnosis.

Implications for Biomedical Research

The impact of RCoV infection on biomedical research cannot be overstated. As a naturally occurring pathogen in rat colonies, RCoV can confound experimental results in several ways:

1. Alteration of Immune Responses: RCoV infection can modulate the host immune system, potentially affecting the outcome of studies involving immunology, vaccine development, or infectious disease models. The virus can induce a Th1-type immune response, with production of interferon-gamma and other cytokines, which may interfere with the response to experimental treatments or pathogens.
2. Gastrointestinal Physiology: RCoV-induced enteritis can alter gut barrier function, nutrient absorption, and the composition of the gut microbiota. This is particularly problematic for studies of metabolism, nutrition, or the gut-brain axis.
3. Respiratory Function: Even mild respiratory infection can alter pulmonary physiology, including airway resistance, mucus production, and alveolar-capillary permeability. This can confound studies of respiratory toxicology, asthma, or chronic obstructive pulmonary disease (COPD).
4. Interference with Experimental Agents: The use of antiviral drugs or immunomodulatory agents in experimental protocols may interact with RCoV infection, leading to unexpected results. For example, the evaluation of repurposed COVID-19 therapeutics in healthy rats by Ozhan et al. (2026) demonstrated that drugs such as hydroxychloroquine, favipiravir, and molnupiravir can induce histopathological changes and immunoreactivity in the heart and lungs, independent of viral infection [29]. These drug effects could be additive or synergistic with RCoV-induced pathology, complicating data interpretation.

Given these potential confounding effects, it is essential that research facilities maintain rigorous health monitoring programs to detect and eliminate RCoV from breeding and experimental colonies. The use of sentinel animals, regular serological screening, and strict biosecurity protocols are standard practices. When RCoV is detected, the affected colony should be quarantined, and a decision must be made regarding depopulation or rederivation, depending on the research goals and the value of the animals.

Zoonotic and One Health Considerations

While RCoV is not considered a zoonotic pathogen, the study of coronaviruses in rats has broader implications for public health and the One Health initiative. Rats, as synanthropic rodents, can serve as reservoirs or intermediate hosts for a variety of pathogens, including coronaviruses. The molecular phylogeny of coronaviruses and their host receptors, as analyzed by Bentum et al. (2022), has revealed subgenome-level conservation, crossover, and divergence among domestic and close-contact animals [1]. The presence of a polybasic furin cleavage motif in several β-coronaviruses of animals points to the existence of intermediate hosts for SARS-CoV-2 and offers a counternarrative to the theory of a laboratory-engineered virus [1]. Understanding the ecology of coronaviruses in rat populations is therefore relevant to predicting and preventing future zoonotic spillover events. The World Health Organization (WHO) and the World Organisation for Animal Health (WOAH) have emphasized the need for surveillance of coronaviruses in animal populations, including rodents, as part of a comprehensive One Health strategy.

Furthermore, the use of rats as animal models for human coronavirus diseases, such as COVID-19, requires a thorough understanding of their natural coronavirus infections. The absorption, distribution, metabolism, and excretion of antiviral drugs, such as the 3CLpro inhibitor SHEN211, have been studied in rats to predict human pharmacokinetics [7]. Similarly, the cardiopulmonary effects of repurposed COVID-19 therapeutics have been evaluated in healthy rat models [29]. These studies rely on the assumption that the rat model is free from confounding viral infections. Therefore, the clinical pathology of RCoV is not merely an academic curiosity but a practical consideration for translational research.

Diagnostic Strategies for Rat Coronavirus Detection

The detection of rat coronavirus (RCV) presents a unique constellation of diagnostic challenges and opportunities, rooted in the virus’s biology, its subclinical presentation in many hosts, and the specific contexts in which testing is most often required. Unlike the high-throughput, politically charged diagnostic surge seen with SARS-CoV-2 in humans [2, 9, 10], RCV diagnostics typically operate within the more controlled, but equally demanding, environments of biomedical research facilities, barrier colonies, and specialized veterinary diagnostic laboratories. The diagnostic strategy must therefore be tailored to the purpose: rapid screening for colony health surveillance, confirmation of suspect clinical cases, research into viral pathogenesis and host response, and the exclusion of closely related coronaviruses that might confound experimental results. This section provides an exhaustive examination of the available and developing diagnostic modalities, their underlying principles, performance characteristics, and appropriate applications, synthesizing data from the broader coronavirus literature with the sparse but critical studies directly addressing RCV.

Molecular Detection: The Cornerstone of Contemporary Diagnosis

Reverse transcription polymerase chain reaction (RT-PCR) and its quantitative variant (RT-qPCR) constitute the gold standard for active RCV infection diagnosis, a position universally supported across coronavirus diagnostics [1, 2, 5, 8]. The approach targets the viral RNA genome, offering exquisite sensitivity and specificity compared to culture or antigen detection methods.

Assay Design and Target Selection

The design of robust RT-PCR assays for RCV must account for the genomic diversity and potential for recombination, a hallmark of coronaviruses [1]. The spike (S), membrane (M), and nucleocapsid (N) protein genes are common targets. However, the S gene is under significant selective pressure from host immune responses and exhibits high variability, particularly in the S1 domain responsible for receptor binding. While targeting the S gene offers the potential for strain differentiation or the detection of specific variants (e.g., pantropic vs. enteric strains), it carries a risk of false negatives if primers do not anneal to a divergent field strain. The N gene and the RNA-dependent RNA polymerase (RdRp) region within the open reading frame (ORF) 1ab are far more conserved across coronaviruses, making them ideal for pan-coronavirus screening or for highly sensitive detection of RCV. For RCV specifically, targeting the conserved replicase gene is recommended as the primary screening tool to maximize sensitivity, with S-gene assays reserved for subsequent genotyping or molecular epidemiology.

The importance of primer set validation cannot be overstated. A comparative evaluation of three PCR primer sets for detecting Trypanosoma lewisi in wild rodents revealed dramatic differences in diagnostic sensitivity, with the LEW1S/LEW1R set achieving 100% sensitivity while another set (TC121/TC122) languished at 67.86% [25]. This principle applies equally to viral diagnostics. Published reference primers for RCV should be validated against a genetically diverse panel of local isolates, not just the lab-adapted prototype strain. A study by Brito and colleagues (2026) on bovine coronavirus (BCoV) demonstrated that reference genome choice significantly impacts detection by metatranscriptomic sequencing; mapping to study-assembled genomes markedly increased read counts compared to the NCBI RefSeq [3]. This highlights a critical methodological consideration: reliance on a single, potentially divergent reference genome for primer design or sequence alignment can lead to substantial under-detection of field strains.

Quantitative RT-PCR (RT-qPCR): Beyond Detection

RT-qPCR provides a quantitative readout of viral load via the cycle threshold (Ct) value, an invaluable parameter for clinical interpretation and research. For RCV in rats, viral load correlates with disease severity and the stage of infection. High viral loads (low Ct values, typically <25-30) are characteristic of active, replicating infection and are most frequently associated with clinical signs such as stunted growth in pups or respiratory distress in adult rats [3]. Low viral loads (high Ct values, >30-35) can represent the tail end of an infection, a subclinical carrier state, or even residual nucleic acid from a resolved infection. Ct values are also critical for assessing the likelihood of virus isolation in cell culture, as successful isolation is highly correlated with samples having Ct values below a threshold (e.g., <27.7 for SARS-CoV-2) [13]. In a colony health context, a single positive RT-qPCR result in a group may warrant immediate isolation and testing of contact animals, while the Ct value helps prioritize which animals are most likely to be actively shedding and infectious.

Point-of-Care Molecular Diagnostics: Emerging Technologies

While laboratory-based RT-PCR remains the standard, point-of-care (POC) molecular tests are gaining traction. For SARS-CoV-2, studies have shown that POC qPCR platforms can achieve sensitivities (84.27%) comparable to fluorescent rapid antigen tests and significantly higher than conventional rapid antigen tests (51.69%) [6]. Although these specific platforms are not yet validated for RCV, the principle is transferable. A POC qPCR could allow a veterinary research facility to obtain a laboratory-quality molecular result within 30-60 minutes at the cage side, dramatically accelerating decisions on quarantine or culling. The development of such assays for RCV, perhaps leveraging isothermal amplification methods (e.g., loop-mediated isothermal amplification, LAMP), represents a significant future opportunity for improved colony management.

Serological Diagnostics: Unveiling the History of Infection

Detection of anti-RCV antibodies is the primary method for determining prior exposure, monitoring the immune status of a colony, and identifying animals that have been infected but have cleared the virus. Unlike molecular tests, serology detects the host’s adaptive immune response, which persists long after viral RNA is no longer detectable.

Enzyme-Linked Immunosorbent Assay (ELISA)

The indirect ELISA is the workhorse of large-scale serological surveillance for coronaviruses. A recombinant viral antigen, most typically the conserved N protein, is used to coat a microtiter plate. Serum or plasma from the test rat is added, and any bound antibodies are detected using an anti-rat IgG conjugate. This platform is highly amenable to automation and can handle hundreds of samples per day. The development of a robust indirect ELISA for RCV requires careful selection of the coating antigen. Using the full-length N protein is common, as it is immunogenic and highly expressed during infection. However, cross-reactivity with other rodent coronaviruses, such as mouse hepatitis virus (MHV), is a constant concern due to the phylogenetic conservation of the N protein [1]. Some assays incorporate the less conserved S1 domain of the spike protein to improve specificity, though this may come at the cost of sensitivity to divergent strains.

A well-validated ELISA must undergo rigorous cutoff determination to achieve high sensitivity and specificity. A study developing a new FCoV ELISA achieved 93.5% sensitivity and 100% specificity against the gold-standard immunofluorescence antibody test (IFAT) [22]. This level of performance, achieved through extensive optimization of reagent concentrations and cutoff methods, serves as a benchmark for RCV ELISA development. False positives from non-specific binding (e.g., from animals with polyclonal B cell activation due to other infections) or from residual maternal antibodies in young pups must be considered. Conversely, false negatives can occur during the early window period (the first 7-10 days post-infection) before seroconversion, or in severely immunocompromised animals that mount a weak antibody response.

Immunofluorescence Assay (IFA)

The IFA, often used as the confirmatory or reference test for coronavirus serology, involves incubating test serum on a slide fixed with RCV-infected cells. The specific binding of antibodies is visualized using a fluorescently labeled secondary antibody. While highly specific and providing a visual confirmation of antigen-antibody binding, IFA is more labor-intensive, requires trained microscopists for interpretation, and is less suitable for high-throughput screening than ELISA. It remains an essential tool for resolving equivocal ELISA results and for research applications where qualitative confirmation of seropositivity is needed.

Virus Neutralization Test (VNT)

The VNT is the most specific serological test, as it measures the ability of serum antibodies to neutralize live virus infectivity in cell culture. This test detects functional antibodies against the viral surface proteins (primarily Spike) that block viral entry into host cells. While the VNT is highly specific and can discriminate between closely related virus serotypes, it is time-consuming (requires several days for cytopathic effect), requires biosafety level 2 (BSL-2) facilities for handling live RCV, and is not suitable for mass screening. It is the gold standard for confirming a seroconversion event or for evaluating vaccine-induced immune responses. The presence of neutralizing antibodies is likely the best correlate of protection against future reinfection.

Antigen Detection: The Role of Rapid Tests and Immunohistochemistry

Antigen detection tests offer the unique advantage of identifying active infection by detecting viral proteins directly in clinical specimens. They provide a snapshot of current viral replication, in contrast to serology which reflects past exposure.

Rapid Antigen Tests (RATs)

For SARS-CoV-2, RATs have been extensively evaluated. Across multiple studies, their performance has been consistently characterized by very high specificity (typically >98-100%) but moderate and highly variable sensitivity (ranging from 28.8% to 98.36% depending on the brand, the population tested, and the viral load) [2, 8, 9, 14]. The sensitivity is critically dependent on the viral load, performing best (often >90%) in samples with high viral loads (Ct <25) [12]. For RCV, a RAT could serve as a rapid, low-cost, and instrument-free point-of-care tool. However, the sensitivity limitations are particularly problematic in rat colonies. RCV infections are frequently subclinical or paucisymptomatic, meaning animals may present for testing with very low viral loads. In a study evaluating SARS-CoV-2 RATs, the overall sensitivity was only 51.69% compared to RT-PCR [6]. Such a poor sensitivity would make a RAT an unreliable tool for determining the true infection status of a single rat, especially in a research colony where an error could have profound experimental consequences.

Despite these limitations, a high-specificity RAT could have a role in emergency outbreak response, as a complement to PCR. A strategy of “preemptive RAT” followed by confirmatory RT-PCR, as proposed by Pan et al. (2026) for community COVID-19 outbreaks, could be applied [2]. In a facility with a sudden outbreak of respiratory or enteric disease, a RAT could be used as a first-line screening tool to rapidly isolate animals with the highest probability of being infectious (high viral load), with the definitive diagnosis provided by PCR. The low positive predictive value of a RAT in a low-prevalence setting is a major limitation, and negative RAT results must always be confirmed by a molecular method [2, 5].

Immunohistochemistry (IHC) and In Situ Hybridization (ISH)

For definitive diagnosis in tissue sections, particularly on postmortem examination, IHC for viral antigen and ISH for viral RNA are invaluable. These techniques allow the pathologist to directly visualize the cellular tropism of the virus within affected tissues, such as the cytoplasm of enterocytes in the small intestine or the epithelium of the respiratory tract. IHC using monoclonal or polyclonal antibodies against the N protein is the most established method. ISH, using probes targeting the viral RNA, can be even more sensitive and is less susceptible to issues of antibody cross-reactivity. These techniques are not for routine antemortem diagnosis but are essential for confirming a pathologic diagnosis, characterizing the nature of an outbreak, and for research into the pathogenesis of RCV infection.

Virus Isolation: The Definitive Standard for Infectious Virus

Isolation of RCV in cell culture remains the definitive proof of the presence of replication-competent virus. This is a critical distinction from molecular tests that cannot distinguish between infectious virions and non-infectious viral debris. Common cell lines susceptible to RCV include L2 (rat lung) and NCTC 1469 (mouse liver) cells. However, virus isolation is laborious, slow (can take 5-10 days), requires expert technical skill, and depends on the presence of infectious virus in the sample. A study on SARS-CoV-2 demonstrated that virus isolation was most successful only in samples with Ct values <25 [13], further emphasizing the need for high viral loads. Given the fastidious nature of RCV and the low viral burden in many subclinical carriers, virus isolation is rarely used for routine diagnosis but is essential for research purposes, for archiving viral isolates, and for characterizing new variants.

Multi-Modal Diagnostic Strategy for the Rat Colony

The selection of a diagnostic strategy for RCV must be governed by a clear objective. For routine health surveillance of a barrier-maintained colony, a combination of serology (e.g., ELISA) on sentinel animals and RT-qPCR on fecal or cecal samples is the standard of care. Serology provides historical data on the colony’s exposure, while PCR provides a real-time snapshot of active shedding. For investigating a suspect outbreak of enteritis or respiratory disease, the priority is rapid molecular confirmation from affected animals. Antemortem, RT-qPCR on fecal swabs is the test of choice. Postmortem, a full panel including RT-qPCR on intestinal and lung tissue, histopathology, and IHC should be performed to confirm the diagnosis and rule out other pathogens.

The comparative performance of these strategies is summarized below.

The Pervasive Challenge of Cross-Reactivity and Recombination

A singular diagnostic challenge for RCV is the potential for cross-reactivity and genomic recombination with other rodent coronaviruses, particularly the highly prevalent mouse hepatitis virus (MHV) [1, 18]. The S protein of some RCV strains is more closely related to the S protein of the transmissible gastroenteritis virus (TGEV) than to other coronaviruses, illustrating the promiscuity of these genetic elements [19]. This means that an ELISA based on the N protein of a single RCV strain may not reliably discriminate antibodies induced by an RCV infection from those induced by an MHV infection, or vice versa. This cross-reactivity is a constant source of error in serological surveillance of mixed-species facilities. Similarly, recombination between RCV and other alphacoronaviruses in the laboratory or in wild rodents could generate new chimeric viruses with altered host range or tropism, further confounding diagnostic efforts [1, 27]. Diagnostic laboratories must therefore maintain a high index of suspicion and use multiplexed assays targeting multiple genes (e.g., S, N, and ORF1ab) to confidently identify a virus as RCV and to characterize its genomic composition.

References to International Standards and Future Directions

While the World Organisation for Animal Health (WOAH) does not list RCV as a notifiable disease, the diagnostic principles remain aligned with WOAH standards for molecular and serological testing of other animal coronaviruses. The World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC) have established rigorous validation guidelines for SARS-CoV-2 diagnostics [12, 32] which serve as a valuable template for veterinary assays, emphasizing the need for well-defined sensitivity, specificity, and reproducibility metrics. Future directions for RCV diagnostics include the development of species-specific multiplex assays that can simultaneously detect RCV, Sendai virus, and Pneumocystis carinii from a single swab, and the integration of next-generation sequencing (e.g., metatranscriptomics) for unbiased detection of emerging pathogens in research colonies [3]. The field must move toward standardized, validated, and openly available detection protocols to ensure the integrity of the vast body of research that relies on rats as model organisms.

References

[1] Bentum KE, Shaddox S, Ware C, Reddy G, Abebe W, Folitse R, et al.. Molecular phylogeny of coronaviruses and host receptors among domestic and close-contact animals reveals subgenome-level conservation, crossover, and divergence. BMC Veterinary Research. 2022. DOI: https://doi.org/10.1186/s12917-022-03217-4

[2] Pan Y, Liu Y, Jiang Y, Cai J. Preemptive rapid antigen test as an emergency measure during coronavirus disease 2019 outbreaks. Frontiers in Public Health. 2026. DOI: https://doi.org/10.3389/fpubh.2026.1764471

[3] Brito B, Frost M, Webster J, To J, Kirkland PD. Quantifying the impact of sequencing depth and reference genome choice on metatranscriptomic detection of four bovine RNA viruses.. Research in Veterinary Science. 2026. DOI: https://doi.org/10.1016/j.rvsc.2026.106125

[4] M.G. V, Tripura M, Soundarya D, S. GS, P. KB, S. G, et al.. Acute Oral Toxicity Study of Exapar Premix in Wistar Rats: A Polyherbal Formulation for Uterine Cleansing and Restoration in Veterinary Practice. Journal of Scientific Research and Reports. 2025. DOI: https://doi.org/10.9734/jsrr/2025/v31i113711

[5] Reshma O, Ajimsha A, Krishna G, Deepthi K, Subhash K, Jitendranath A, et al.. Evaluation of rapid antigen test against reverse transcription-polymerase chain reaction for the diagnosis of severe acute respiratory syndrome coronavirus 2 in a tertiary care centre in South Kerala. Journal of The Academy of Clinical Microbiologists. 2022. DOI: https://doi.org/10.4103/jacm.jacm_70_21

[6] Lam SC, Su JJ, Tsang S, Wong AON, Pang VCM, Chung JYS, et al.. Diagnostic accuracy of point-of-care testing methods for SARS-CoV-2 detection in community quarantine and isolation settings. Infection Prevention in Practice. 2025. DOI: https://doi.org/10.1016/j.infpip.2025.100496

[7] Zhang Z, Jia M, Wang F, Yang C, Shi H, Yuan Y, et al.. Absorption, distribution, metabolism, and excretion of [14C]SHEN211, a nonpeptidic small-molecule 3CLpro inhibitor, in rats.. Journal of Pharmacology and Experimental Therapeutics. 2025. DOI: https://doi.org/10.1016/j.jpet.2025.103623

[8] Abebe B, Birhane N, Girmay G, Belete D. Evaluating the sensitivity and specificity of a rapid antigen screening test against real-time polymerase chain reaction for COVID-19 detection in northern Ethiopia. Journal of Life Science and Biomedicine. 2024. DOI: https://doi.org/10.54203/jlsb.2024.12

[9] Lee J, Jung J, Jo JL, Lim Y, Kim S, Yang H, et al.. Usefulness of the Rapid Antigen Test in Detecting SARS-CoV-2 for Infection Control in Hospitals. Infection & Chemotherapy. 2023. DOI: https://doi.org/10.3947/ic.2023.0077

[10] Chi H, Chiu N, Chen C, Weng S, Lien C, Lin C, et al.. To PCR or not? The impact of shifting policy from PCR to rapid antigen tests to diagnose COVID-19 during the omicron epidemic: a nationwide surveillance study. Frontiers in Public Health. 2023. DOI: https://doi.org/10.3389/fpubh.2023.1148637

[11] Mak G, Lau SSY, Wong KKY, Lau C, Ng KH, Lam E, et al.. Analytical sensitivity of the Rapid Antigen Test kits for detection of SARS‐CoV‐2 Omicron variant BA.2 sublineage. Journal of Medical Virology. 2022. DOI: https://doi.org/10.1002/jmv.27908

[12] Seitz T, Lickefett B, Traugott M, Pawelka E, Karolyi M, Baumgartner S, et al.. Evaluation of Five Commercial SARS-CoV-2 Antigen Tests in a Clinical Setting. Journal of general internal medicine. 2022. DOI: https://doi.org/10.1007/s11606-022-07448-x

[13] Chao T, Lee W, Hu H, Lin Y, Ho S, Chen H, et al.. Clinical assessment of SARS-CoV-2 infectivity by rapid antigen test compared with virus isolation. Journal of Clinical Virology Plus. 2022. DOI: https://doi.org/10.1016/j.jcvp.2022.100133

[14] Ismail G, Abdelhamid D, Halim RA, Mostafa M, Abdelghaffar H, Fahim NAE, et al.. Comparative Evaluation of Different SARS-CoV-2 Rapid Point-of-Care Antigen Tests with SARS-CoV-2 PCR for Diagnosis of COVID-19. Open Access Macedonian Journal of Medical Sciences. 2022. DOI: https://doi.org/10.3889/oamjms.2022.10335

[15] Gélinas A, Boutin M, Sasseville A, Dea S. Bovine coronaviruses associated with enteric and respiratory diseases in Canadian dairy cattle display different reactivities to anti-HE monoclonal antibodies and distinct amino acid changes in their HE, S and ns4.9 protein. Virus Research. 2001. DOI: https://doi.org/10.1016/S0168-1702(01)00243-X

[16] Pulss S, Stolle I, Stamm I, Leidner U, Heydel C, Semmler T, et al.. Multispecies and Clonal Dissemination of OXA-48 Carbapenemase in Enterobacteriaceae From Companion Animals in Germany, 2009, 2016. Frontiers in Microbiology. 2018. DOI: https://doi.org/10.3389/fmicb.2018.01265

[17] Zheng Y, Feng J, Yu Y, Ling M, Song Y, Xie H, et al.. Anti-Coronavirus Potential of Polyether Ionophores: The New Application of Veterinary Antibiotics in Livestock.. Journal of Agricultural and Food Chemistry. 2024. DOI: https://doi.org/10.1021/acs.jafc.4c01130

[18] Xiong H, Morrison J, Ferris M, Gralinski LE, Whitmore A, Green R, et al.. Genomic Profiling of Collaborative Cross Founder Mice Infected with Respiratory Viruses Reveals Novel Transcripts and Infection-Related Strain-Specific Gene and Isoform Expression. G3: Genes, Genomes, Genetics. 2014. DOI: https://doi.org/10.1534/g3.114.011759

[19] Wesley R. The S gene of canine coronavirus, strain UCD-1, is more closely related to the S gene of transmissible gastroenteritis virus than to that of feline infectious peritonitis virus. Virus Research. 1999. DOI: https://doi.org/10.1016/S0168-1702(99)00032-5

[20] Museux K, Arcari G, Rodrigo G, Hennart M, Badell E, Toubiana J, et al.. Corynebacterium of the diphtheriae complex in companion animals: clinical and microbiological characterization of 64 cases from France. bioRxiv. 2023. DOI: https://doi.org/10.1101/2023.01.04.522820

[21] Hornok S, Beck R, Farkas R, Grima A, Otranto D, Kontschán J, et al.. High mitochondrial sequence divergence in synanthropic flea species (Insecta: Siphonaptera) from Europe and the Mediterranean. Parasites & Vectors. 2018. DOI: https://doi.org/10.1186/s13071-018-2798-4

[22] Ferrero I, Dewilde S, Poletti P, Canepa B, Giachino E, Dall'Ara P, et al.. Development of a New Indirect ELISA Test for the Detection of Anti-Feline Coronavirus Antibodies in Cats. Veterinary Sciences. 2025. DOI: https://doi.org/10.3390/vetsci12030245

[23] Radzіkhovskyі N, Dyshkant О, Tolokevich O, Moshkivsky V. EPIZOOTOLOGICAL FEATURES CORONAVIRUS INFECTION IN CATS. Scientific and Technical Bulletin оf State Scientific Research Control Institute of Veterinary Medical Products and Fodder Additives аnd Institute of Animal Biology. 2021. DOI: https://doi.org/10.36359/scivp.2021-22-2.37

[24] Stokol T, Brandt LE, Shuman M, Jeffery D, Blank BS, Silvela EJ, et al.. Hematologic and Biochemical Reference Intervals and Urinary Test Results for Wild-caught Adult Southern Giant Pouched Rats (Cricetomys ansorgei).. Journal of the American Association for Laboratory Animal Science. 2021. DOI: https://doi.org/10.30802/aalas-jaalas-20-000154

[25] Yudhana A, Santosa GAIP, Wardhana AH, Putra FL, Edila R, Sawitri D, et al.. Comparative evaluation of three polymerase chain reaction primer sets for accurate molecular detection of Trypanosoma lewisi in wild rodents in Indonesia. Veterinary World. 2025. DOI: https://doi.org/10.14202/vetworld.2025.2395-2405

[26] Huynh M, Pignon C. Gastrointestinal Disease in Exotic Small Mammals. Journal of Exotic Pet Medicine. 2013. DOI: https://doi.org/10.1053/j.jepm.2013.05.004

[27] Santana-Clavijo NF, Romero D, Fajardo D, Muñoz A, Taniwaki S, Silva SOS, et al.. Molecular diversity of Alphacoronavirus 1 in dogs and cats in Colombia. Heliyon. 2020. DOI: https://doi.org/10.1016/j.heliyon.2020.e04381

[28] Al.Bayati HAM, Al.khateeb ZD. Molecular Characterization of Canine Coronavirus Strains Circulating in Baghdad and Wasit Provinces, Iraq. Natural and Engineering Sciences. 2025. DOI: https://doi.org/10.28978/nesciences.1811142

[29] Ozhan O, Yıldız A, Bakar B, Ulu A, Kucukakcali Z, Karaca E, et al.. Evaluation of the cardiopulmonary effects of repurposed COVID-19 therapeutics in healthy rats. Scientific Reports. 2026. DOI: https://doi.org/10.1038/s41598-025-31048-4

[30] Bertani V, Blanck O, Guignard D, Schorsch F, Pischon H. Artificial Intelligence in Toxicological Pathology: Quantitative Evaluation of Compound-Induced Follicular Cell Hypertrophy in Rat Thyroid Gland Using Deep Learning Models. Toxicologic pathology (Print). 2021. DOI: https://doi.org/10.1177/01926233211052010

[31] Michael H, Waterhouse T, Estrada M, Seguin M. Frequency of respiratory pathogens and SARS‐CoV‐2 in canine and feline samples submitted for respiratory testing in early 2020. Journal of Small Animal Practice. 2021. DOI: https://doi.org/10.1111/jsap.13300

[32] Khanh NV, Binh NTT, Thu DK, Linh DTT, Anh VTN, Giang VTT, et al.. Simultaneous Determination of Cortisol and Testosterone from Rat Serum by Liquid Chromatography-Tandem Mass Spectrometry. VNU Journal of Science Medical and Pharmaceutical Sciences. 2022. DOI: https://doi.org/10.25073/2588-1132/vnumps.4394